肾癌根治术后局部腹膜后复发的手术治疗:33例回顾性分析
该研究回顾性分析33例肾癌根治术后局部腹膜后复发患者的手术治疗资料,其中29例完整切除、4例姑息手术;中位术中出血500 ml,无Clavien Ⅲ~Ⅴ级并发症;术后中位生存31个月,1年与3年生存率分别为86.8%和36.9%,提示手术安全且术后靶向治疗可能带来生存获益。
要点
- 肾癌根治术后严密影像学复查有助于早期发现局部复发并预测手术切除完整性。
- 局部复发病灶切除术中出血较多,但安全、术后并发症可控。
- 术后靶向治疗可能为局部复发患者提供更好的生存获益。
核心结论
- 肾癌根治术后局部腹膜后复发病灶手术虽出血相对较多,但安全且并发症可控。
- 术后靶向治疗可能使局部复发患者生存获益。
研究设计与样本
- 回顾性分析2010年1月至2018年4月仁济医院33例肾癌根治术后局部复发行复发病灶切除术患者的临床和随访资料。
- 33例中男25例、女8例,中位年龄54岁;根治时病理分期pT1~2N0M0期14例、pT3~4N0M0期16例、pN1期3例。
主要发现
- 仅4例复发时有症状,其余均为根治术后随访影像学检查发现;中位复发时间30个月,中位复发肿瘤直径4.5 cm。
- 29例完整切除局部复发病灶,4例无法完整切除转为姑息手术;中位术中出血500 ml,术后中位住院时间4 d。
- 术后5例出现ClavienⅠ~Ⅱ级并发症,无Ⅲ~Ⅴ级严重并发症;6例术后使用靶向药物,其中1例出现远处转移。
- 未行辅助治疗的27例中12例术后出现远处转移。
- 33例局部复发术后中位生存时间31个月,1年和3年生存率分别为86.8%和36.9%。
临床怎么用
- 肾癌根治术后应严密影像学复查,以尽早发现局部复发病灶并预判手术切除完整性。
- 对局部复发病灶可考虑手术切除,需注意术中出血相对较多但并发症可控。
- 局部复发术后可考虑靶向治疗以争取生存获益。
局限性
- 本研究为单中心回顾性分析,样本量33例。
- 术后靶向治疗组仅6例,非随机对照,生存获益结论需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the therapeutic effects of surgical management for local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy. Methods: Clinical and follow-up data of 33 cases of local recurrence after radical nephrectomy in Renji Hospital from January 2010 to April 2018 were retrospectively analyzed. Results: In these 33 patients, 25 was male and 8 was female; The median age was 54 years old. The pathological stage of radical nephrectomy included 14 cases of pT1-2N0M0 stage, 16 cases of pT3-4 N0M0 stage, and 3 cases of pN1 stage. Only 4 relapsing patients had symptoms, the others were all found to have recurrence by imaging examination during follow up period of postoperation.The median recurrence time for all patients was 30 months, and the median diameter of recurrent tumors was 4.5 cm.Twenty-nine patients underwent complete resection of local recurrent lesions, and 4 patients whose recurrent lesions could not be completely resected converted receive palliative surgery. The median intraoperative blood loss was 500 ml and the median hospital stay after surgery was 4 days. Clavien grade Ⅰ-Ⅱ complications occurred in 5 patients after surgery, and no serious complications of Clavien grade Ⅲ-Ⅴ complications occurred. Six patients received postoperative adjuvant target therapy and distant metastasis occurred in one patient.In the 27 patients without adjuvant target therapy, postoperative distant metastases occurred in 12 patients. The median survival time for all patients after local recurrence surgery was 31 months. The 1-year and 3-year survival rates were 86.8% and 36.9%, respectively. Conclusions: The rigorous imaging examination after radical nephrectomy can detect local recurrent lesions as early as possible in most relapsing patients and imaging examination can predict the integrity of surgical resection of local recurrence.Although intraoperative bleeding of resection of local recurrence is relatively high, the operation is safe and the postoperative complications are controllable. Postoperative adjuvant therapy may also provide better survival benefit for patients with local recurrence. 目的: 探讨肾癌根治术后局部复发患者手术治疗的疗效。 方法: 回顾性分析2010年1月至2018年4月在上海交通大学医学院附属仁济医院行肾癌根治术后局部复发病灶切除术的33例患者的临床和随访资料。 结果: 33例患者中,男25例,女8例;中位年龄54岁。行根治性肾切除术时的病理分期为pT1~2N0M0期14例,pT3~4N0M0期16例,pN1期3例。仅有4例患者复发时出现症状,其他均为根治术后随访影像学检查发现。33例患者的中位复发时间为30个月,中位复发肿瘤直径4.5 cm。所有患者均行开放手术,其中29例患者完整切除局部复发病灶,4例患者无法完整切除复发病灶转为姑息手术。中位术中出血500 ml,术后中位住院时间为4 d。术后5例患者出现ClavienⅠ~Ⅱ级并发症,无Ⅲ~Ⅴ级严重并发症发生。6例患者术后使用靶向药物治疗,其中1例患者术后出现远处转移。未行辅助治疗的27例患者中,有12例患者术后出现远处转移。33例局部复发患者术后中位生存时间为31个月,1年和3年生存率分别为86.8%和36.9%。 结论: 肾癌根治术后严密影像学复查可以尽可能地在局部复发患者中尽早发现局部复发病灶,并对局部复发的手术切除完整性有预测作用。肾癌根治术后局部复发的手术虽然出血相对较多,但手术安全,术后并发症可控。术后靶向治疗可能使局部复发患者生存获益。.
引用
- Huang JW, Cai W, Kong W, et al. [Surgical management for local retroperitoneal recurrence of 33 renal cell carcinoma patients underwent radical nephrectomy]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31550862. doi:10.3760/cma.j.issn.0253-3766.2019.09.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。